Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
264.56
-3.34 (-1.25%)
Aug 17, 2026, 4:00 PM EDT - Market closed
Tenet Healthcare Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Tenet Healthcare stock has a consensus rating of "Buy" and an average price target of $282.48. The average 1-year stock price forecast is 6.77% higher than the current stock price, while the lowest is $260 (-1.72%) and the highest is $309 (+16.80%).
Price Target: $282.48 (+6.77%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tenet Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 14 | 14 |
| Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $250 → $290 | Buy | Maintains | $250 → $290 | +9.62% | Aug 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $290 → $295 | Buy | Reiterates | $290 → $295 | +11.51% | Aug 10, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $231 → $281 | Buy | Reiterates | $231 → $281 | +6.21% | Jul 31, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Buy Reiterates $252 → $305 | Buy | Reiterates | $252 → $305 | +15.29% | Jul 28, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $242 → $283 | Buy | Maintains | $242 → $283 | +6.97% | Jul 28, 2026 |
Financial Forecast
Revenue This Year
22.43B
from 21.31B
Increased by 5.24%
Revenue Next Year
22.53B
from 22.43B
Increased by 0.47%
EPS This Year
21.21
from 16.78
Increased by 26.39%
EPS Next Year
20.83
from 21.21
Decreased by -1.79%
EPS and Forward PE are based on non-GAAP adjusted numbers.